You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Litigation Details for Bausch Health Ireland Limited v. Lupin Ltd. (D. Del. 2019)

✉ Email this page to a colleague

« Back to Dashboard

Bausch Health Ireland Limited v. Lupin Ltd. (D. Del. 2019)

Docket	⤷ Sign Up	Date Filed	2019-04-03
Court	District Court, D. Delaware	Date Terminated	2019-08-05
Cause	35:271 Patent Infringement	Assigned To	Colm Felix Connolly
Jury Demand	None	Referred To
Patents	10,016,504; 8,999,313; 9,326,969; 9,592,252; 9,707,297
Attorneys	John C. Phillips , Jr.
Firms	Phillips, McLaughlin & Hall, P.A.
Link to Docket	External link to docket

Small Molecule Drugs cited in Bausch Health Ireland Limited v. Lupin Ltd.

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Details for Bausch Health Ireland Limited v. Lupin Ltd. (D. Del. 2019)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2019-04-03	1	Complaint	(“the ʼ252 patent”); 9,707,297 B2 (“the ʼ297 patent”); and 10,016,504 B2 (“the ʼ504 patent”) arising …United States Patent Nos. 8,999,313 B2 (“the ʼ313 patent”); 9,326,969 B2 (“the ʼ969 patent”); 9,592,252…the ’313 patent; claims 1–9 of the ’252 patent; claims 1–6, 8–18, and 20–24 of the ’297 patent; and claims… THE PATENTS IN SUIT 29. The U.S. Patent and Trademark Office (“PTO…PTO”) issued the ’313 patent on April 7, 2015. The ’313 patent claims, inter alia, compositions for admixture	External link to document
2019-04-03	4	Patent/Trademark Report to Commissioner of Patents	;9,326,969 B2 ;9,592,252 B2 ;9,707,297 B2 ;10,016,504 B2. (nmg) (Entered: 04/04/2019) 3 April 2019… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,999,313 B2 ;…2019 5 August 2019 1:19-cv-00626 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2019-08-20	9	Patent/Trademark Report to Commissioner of Patents	;9,326,969 B2 ;9,592,252 B2 ;9,707,297 B2 ;10,016,504 B2. (Attachments: # 1 Notice)(fms) (Entered: 08… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,999,313 B2 ;…2019 5 August 2019 1:19-cv-00626 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.